uniQure

uniQure is a leader in the field of gene therapy and has developed the first and, to date, only gene therapy product to receive regulatory approval from the European Union. By directing the expression of therapeutic protein genes or through single administration to repair the expression of missing proteins, gene therapy offers long-term and potentially significant benefits to patients with genetic or acquired diseases.